Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. DrugBank Drug (Description in trials) KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1 HMI-103
(Recombinant adeno-associated viral vector serotype HSC expressing human phenylalanine hydroxylase)		[1] HMI-103---[1] 240 💬
2 Levodopa
(Dihydroxy-L-phenylalanine)		[2] L-dopa; Levodopa[1] Levodopa 💬 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		[13] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[6] 6, 17, 90, 140, 164, 201 💬
3 Melphalan
(Phenylalanine nitrogen mustard)		[2] Melphalan; Melphalan hydrochloride[2] Melphalan ,
Melphalan hydrochloride 💬 		--[19] 11, 13, 14, 19, 20, 28, 34, 46, 60, 62, 65, 96, 107, 164, 222, 234, 284, 285, 299 💬
4 Phenylalanine
(Phenylalanine sodium)		[1] Phenylalanine[1] Phenylalanine (Phenylalanine, L-Phenylalanine) 💬 --[3] 75, 77, 240 💬
5 Tyrosine
(4-hydroxy-L-phenylalanine)		[3] Alanine; Propanoic acid; Tyrosine[1] Tyrosine 💬 --[5] 6, 75, 77, 86, 298 💬